verapamil hydrochloride
- Product NDC
- 10544-035
- 11-digit product format
- 105440035
- Labeler code
- 10544
- Product ID
- 10544-035_cbf00b1c-4767-4d3d-b590-6dfe7425d282
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA078906
- Marketing category
- ANDA
- Marketing start
- 2011-02-15
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 240 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10544-035-30 | verapamil hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VERAPAMIL HYDROCHLORIDE | ACTIVE INGREDIENT | V3888OEY5R | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| VERAPAMIL | ACTIVE MOIETY | CJ0O37KU29 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| SODIUM ALGINATE | INACTIVE INGREDIENT | C269C4G2ZQ | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10544-035 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BLENHEIM PHARMACAL, INC.] | 1 | Legacy NDC, 1 package rows | 20150314_cbf00b1c-4767-4d3d-b590-6dfe7425d282.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10544-035-30 | 10544003530 | 30 in 1 BOTTLE | Historical |